Valneva Aktie
3,66
EUR
-0,07
EUR
-1,93
%
2,16
EUR
-0,55
EUR
-20,34
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Amgen Inc. | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | +19,22% |
BB Biotech AG | 0 | 0 | 0 | - | - |
BioNTech (ADRs) | 4 | 2 | 0 | 136,17 USD | +13,47% |
CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
CureVac | 0 | 1 | 0 | - | - |
EVOTEC SE | 2 | 2 | 1 | 9,68 EUR | +13,88% |
Johnson & Johnson | 0 | 0 | 0 | - | - |
Moderna Inc | 0 | 2 | 1 | 67,33 USD | +89,50% |
MorphoSys | 0 | 1 | 0 | 68,00 EUR | - |
Novavax Inc. | 0 | 0 | 0 | - | - |
QIAGEN N.V. | 4 | 3 | 0 | 45,00 EUR | +20,03% |
Sanofi S.A. | 6 | 2 | 0 | 114,14 EUR | +10,54% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
Valneva | 0 | 0 | 0 | - | - |